This paper is in the following e-collection/theme issue:

Case Report (13) JMIR Theme Issue: COVID-19 Special Issue (2452) Outbreak and Pandemic Preparedness and Management (1727) Infectious Diseases (non-STD/STI) (1575)

Published on in Vol 5, No 4 (2022): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/41739, first published .
Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report

Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report

Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report

Authors of this article:

Fahad Ahmed1 Author Orcid Image ;   Nashwah Memon2 Author Orcid Image ;   Adel Haque3 Author Orcid Image
Article Authors Cited by (2) Tweetations (31) Metrics

Journals

  1. Baeza-Hernández G, Cañueto J. Intralesional Treatments for Invasive Cutaneous Squamous Cell Carcinoma. Cancers 2023;16(1):158 View
  2. Ilaria P, Nevena S, Ersilia T, Federica T, Felice F, Agnieszka Ewa D, Francesco F, Concetta P. Generalized Eruptive Keratoacanthoma (GEKA) after Pfizer mRNABNT162b2 (Comirnaty®) COVID-19 Vaccination Successfully Treated with Cemiplimab. Viruses 2024;16(8):1260 View